|
1
|
Maiborodin I, Mansurova A, Chernyavskiy A, Romanov A, Voitcitctkii V, Kedrova A, Tarkhov A, Chernyshova A, Krasil’nikov S. Cancer Angiogenesis and Opportunity of Influence on Tumor by Changing Vascularization. J Pers Med 2022; 12:jpm12030327. [PMID: 35330327 PMCID: PMC8954734 DOI: 10.3390/jpm12030327] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Revised: 02/18/2022] [Accepted: 02/18/2022] [Indexed: 12/19/2022] Open
Abstract
Based on the study of recent scientific literature devoted to neovascularization and angiogenesis in malignant neoplasms, it was concluded that there are many publications on each of the problems of tumor angiogenesis and vascularization. The formation of blood vessels in a tumor and certain aspects of the prognostic value of the severity of vascularization in almost all forms of cancer are considered. Special attention is paid to the peculiarities of angiogenesis in tumors of the female reproductive system. A large number of vessels in the tumor often indicates a poor prognosis. The influence of various factors on the initiation of angiogenesis and the process itself, as well as the possibility of suppressing such signals to slow down the formation of blood vessels and thus the development of the tumor are widely studied. The results of pharmacological suppression of tumor vessel formation demonstrate a good clinical outcome but one accompanied by a large number of severe adverse side effects. Such a significant amount of studies on each of the problems of tumor vascularization indicates the increasing importance of this area of oncology. At the same time, only a very small number of works are devoted to the study of the differences in angiogenesis and number of vessels between different parts of the tumor, as well as between the primary tumor node and its metastases. The refinement of the results is still to be done. It was noted that the expression of proangiogenic factors in metastases is usually higher than in the source of metastasis, and the expression in lymphogenous metastases is higher than in hematogenous ones.
Collapse
Affiliation(s)
- Igor Maiborodin
- The E. Meshalkin National Medical Research Center, Ministry of Health of Russia, 30055 Novosibirsk, Russia; (A.M.); (A.C.); (A.R.); (V.V.); (A.K.); (A.T.); (S.K.)
- Correspondence:
| | - Alfija Mansurova
- The E. Meshalkin National Medical Research Center, Ministry of Health of Russia, 30055 Novosibirsk, Russia; (A.M.); (A.C.); (A.R.); (V.V.); (A.K.); (A.T.); (S.K.)
| | - Alexander Chernyavskiy
- The E. Meshalkin National Medical Research Center, Ministry of Health of Russia, 30055 Novosibirsk, Russia; (A.M.); (A.C.); (A.R.); (V.V.); (A.K.); (A.T.); (S.K.)
| | - Alexander Romanov
- The E. Meshalkin National Medical Research Center, Ministry of Health of Russia, 30055 Novosibirsk, Russia; (A.M.); (A.C.); (A.R.); (V.V.); (A.K.); (A.T.); (S.K.)
| | - Vladimir Voitcitctkii
- The E. Meshalkin National Medical Research Center, Ministry of Health of Russia, 30055 Novosibirsk, Russia; (A.M.); (A.C.); (A.R.); (V.V.); (A.K.); (A.T.); (S.K.)
| | - Anna Kedrova
- The E. Meshalkin National Medical Research Center, Ministry of Health of Russia, 30055 Novosibirsk, Russia; (A.M.); (A.C.); (A.R.); (V.V.); (A.K.); (A.T.); (S.K.)
| | - Alexander Tarkhov
- The E. Meshalkin National Medical Research Center, Ministry of Health of Russia, 30055 Novosibirsk, Russia; (A.M.); (A.C.); (A.R.); (V.V.); (A.K.); (A.T.); (S.K.)
| | - Alena Chernyshova
- Tomsk National Research Medical Center, Cancer Research Institute, Russian Academy of Sciences, 634009 Tomsk, Russia;
| | - Sergey Krasil’nikov
- The E. Meshalkin National Medical Research Center, Ministry of Health of Russia, 30055 Novosibirsk, Russia; (A.M.); (A.C.); (A.R.); (V.V.); (A.K.); (A.T.); (S.K.)
| |
Collapse
|